COPD — Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients
Citation(s)
Albu A, Fodor D, Bondor C, Suciu O Carotid arterial stiffness in patients with chronic obstructive pulmonary disease. Acta Physiol Hung. 2011 Jun;98(2):117-27. doi: 10.1556/APhysiol.98.2011.2.3.
Andreas S, Anker SD, Scanlon PD, Somers VK Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005 Nov;128(5):3618-24. Review.
Andreas S, Haarmann H, Klarner S, Hasenfuss G, Raupach T Increased sympathetic nerve activity in COPD is associated with morbidity and mortality. Lung. 2014 Apr;192(2):235-41. doi: 10.1007/s00408-013-9544-7. Epub 2013 Dec 22.
Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB Total and state-specific medical and absenteeism costs of COPD among adults aged = 18 years in the United States for 2010 and projections through 2020. Chest. 2015 Jan;147(1):31-45. doi: 10.1378/chest.14-0972.
Macefield VG Sustained activation of muscle sympathetic outflow during static lung inflation depends on a high intrathoracic pressure. J Auton Nerv Syst. 1998 Feb 5;68(3):135-9.
Nardone M, Incognito AV, Millar PJ Evidence for Pressure-Independent Sympathetic Modulation of Central Pulse Wave Velocity. J Am Heart Assoc. 2018 Jan 29;7(3). pii: e007971. doi: 10.1161/JAHA.117.007971.
Wallin BG, Burke D, Gandevia SC Coherence between the sympathetic drives to relaxed and contracting muscles of different limbs of human subjects. J Physiol. 1992 Sep;455:219-33.
Static Lung Hyperinflation and Sympathetic Nerve Activity-Associated Large Artery Stiffness in COPD Patients
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
